CADTH | Evidence Driven
CADTH | Evidence Driven

Switching from Reference to Biosimilar Insulin Lispro for Patients with Diabetes Mellitus Type 1 or 2

Details

Files
Project Status:
Completed
Project Line:
Reference List
Project Sub Line:
Summary of Abstracts
Project Number:
RB1554-000

Question

  1. What is the clinical effectiveness of switching from reference to biosimilar insulin lispro in adult or pediatric patients with diabetes mellitus (type 1 or 2)?

Key Message

One randomized controlled trial was identified regarding the clinical effectiveness of switching from reference to biosimilar insulin lispro in adult or pediatric patients with diabetes mellitus (type 1 or 2).

Files

Switching from Reference to Biosimilar Insulin Lispro for Patients with Diabetes Mellitus Type 1 or 2 Rapid Response February 18, 2021 View PDF

Related Content

Last Updated : February 24, 2021